 |
|
| Blog results | Results 1 - 10 of about 34,875 for fda lamictal. (0.33 seconds) |
| Sorted by relevance Sort by date |
| 2 Feb 2010 storyBody The US FDA has expanded the label of GlaxoSmithKline's once-daily Lamictal XR (lamotrigine) extended release tablets to include add-on treatment of epilepsy in patients aged 13 years and older with primary generalized ... Scrip News - Home - RSS - http://www.scripnews.com/home/ |
| 1 Feb 2010 29 /PRNewswire-FirstCall/ -- GlaxoSmithKline announced today that the U.S. Food and Drug Administration has approved Lamictal®XR™ (lamotrigine) Extended-Release Tablets as once-a-day, add-on therapy for epilepsy in patients ages 13 ... BioSpace.com Featured News and Stories - http://www.biospace.com/ [ More results from BioSpace.com Featured News and Stories ] |
| 1 Feb 2010 UK drug giant GlaxoSmithKline received two pieces of good news from the US Food and Drug Administration last Friday related to its breast cancer drug Tykerb (lapatinib) and Lamictal XR (lamotrigine), currently indicated for epilepsy and ... thepharmaletter.com - http://www.thepharmaletter.com/ |
| 29 Jan 2010 by Rx Times This is an expanded label, as Lamictal XR is approved for partial onset seizures (with or without secondary generalization) for patients in this age group. Primary generalized tonic-clonic seizures, known formerly as “grand mal” ... Rx Times Magazine - http://www.rxtimes.com/ |
| 29 Jan 2010 by PRNewswire FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures PR Newswire RESEARCH TRIANGLE PARK, NC, Your Story - http://www.your-story.org/ [ More results from Your Story ] |
| 29 Jan 2010 by GlaxoSmithKline FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures (HSMN NewsFeed: Medical Devices, Pharmaceuticals and Diagnostics) HSMN NewsFeed - http://salesandmarketingnetwork.com/?q=Save+Us+From+Berlusconi - References |
| 11 May 2009 Lamictal ODT (lamotrigine) is used to treat Bipolar I Disorder and seizures. Includes Lamictal ODT side effects, interactions and indications. Drugs.com - New Drug Approvals - http://www.drugs.com/newdrugs.html [ More results from Drugs.com - New Drug Approvals ] |
| 29 Jan 2010 by GlaxoSmithKline FDA Approves Once-A-Day Lamictal(R)XR(TM) as Add-On Epilepsy Therapy for Primary Generalized Tonic-Clonic Seizures. Friday, January 29, 2010 17:31 EST; FDA Approval, Clinical Trials / Medical Discoveries; Healthcare Equipment, ... Breaking Stock Market News & Blogs - Bullpoo.com - http://www.duedee.com/news/page-1/ |
| 1 Feb 2010 by Jim Marino The FDA has approved GlaxoSmithKline's Lamictal XR extended-release tablets as once-a-day, add-on therapy for epilepsy in patients over 13 years of age suffering from primary generalized tonic-clonic seizures. Lamictal XR is already ... Medical Product Guide» | Medical Product... - http://www.medicalproductguide.com/blog/ |
| 2 Feb 2010 GlaxoSmithKline (NYSE: GSK) announced that the US Food and Drug Administration has approved Lamictal®XR™ (lamotrigine) Extended-Release Tablets as once-a-day, add-on therapy for epilepsy in patients ages 13 years and older with primary ... Pharmainfo.net - Biotechnology news - http://www.pharmainfo.net/biotechnology-news |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
